Results 41 to 50 of about 19,340 (214)
BACKGROUND: The coronavirus disease 2019 pandemic has exposed disproportionate health inequities among underserved populations, including refugees. Public safety net healthcare systems play a critical role in facilitating access to care for refugees and ...
Crista E. Johnson-Agbakwu, MD, MSc +8 more
doaj +1 more source
Structure and genome of severe acute respiratory syndrome Coronavirus 2
SARS-CoV-2 is a novel coronavirus responsible for the current COVID-19 pandemic. It is the seventh coronavirus known to infect humans (the previous human coronaviruses are HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63, SARS-CoV and MERS-CoV) and the third human coronavirus known to cause severe illness in human after SARS-CoV and MERS-CoV.
Ibrahim Hussaini +4 more
openaire +3 more sources
Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies
Purpose of review SARS-CoV2 is a β-coronavirus, isolated for the first time in Wuhan in December 2019. Bilateral interstitial pneumonia is the hallmark of this disease. Liver is the second viral target for frequency and AST and ALT elevation is a common finding.
Bartoli A., Cursaro C., Andreone P.
openaire +3 more sources
Acute Renal Failure in a Patient With Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious viral pathogen with high morbidity and mortality rate. The infection affects multiple organ systems leading to systemic organ failure. There is an increased incidence of acute kidney injury (AKI) in patients who become critically ill.
Ayad, Sarah +4 more
openaire +2 more sources
Reduced frequency of migraine attacks following coronavirus disease 2019: a case report
Background Severe acute respiratory syndrome coronavirus 2 is a virus affecting different organs and causing a wide variety and severity of symptoms. Headache as well as loss of smell and taste are the most frequently reported neurological manifestations
Roland Houben
doaj +1 more source
Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2
What began with a sign of pneumonia-related respiratory disorders in China has now become a pandemic named by WHO as Covid-19 known to be caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The SARS-CoV-2 are newly emerged β coronaviruses belonging to the Coronaviridae family.
Satarker, Sairaj, Nampoothiri, Madhavan
openaire +2 more sources
Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2 [PDF]
A patient presented with an opsoclonus-myoclonus-ataxia syndrome after a 2-week period of fever. In her work as an assistant nurse, she had been exposed to patients infected with severe acute respiratory syndrome coronavirus-2. Laboratory investigations showed that the patient had positive IgG antibodies against this pathogen, and a chest CT showed ...
João Fernandes, Peter Puhlmann
openaire +2 more sources
Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia [PDF]
Coronavirus disease (COVID-19) in Colombia was first diagnosed in a traveler arriving from Italy on February 26, 2020. However, limited data are available on the origins and number of introductions of COVID-19 into the country. We sequenced the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from 43 clinical ...
Katherine Laiton‐Donato +16 more
openaire +5 more sources
Background Like other viral infections, severe acute respiratory syndrome coronavirus-2 infection could affect different human body systems, including host immune responses. Three years after its pandemic, we learn more about this novel coronavirus.
Ali Amanati +7 more
doaj +1 more source
A Family Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections [PDF]
Abstract Background In December 2019, the outbreak of 2019 novel coronavirus disease (COVID-19) began in Wuhan, Hubei Province, China. The disease has rapidly spread from Wuhan to other provinces and other countries. Clinical and epidemiological knowledge is limited.
Xuesong Gao +9 more
openaire +3 more sources

